home / stock / svra / svra articles
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. Shares of Rivian Automotive, Inc. (NASDAQ: RIVN) f...
News, Short Squeeze, Breakout and More Instantly...
Remains On-Track to Report Top Line Data from the Pivotal Phase 3 IMPALA-2 Trial by End of 2Q 2024 48-week placebo-controlled trial is evaluating molgramostim nebulizer solution (molgramostim), a novel inhaled biologic, for the treatment of autoimmune Pulmonary Alveolar Proteinosis (aPAP)...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live web...
Savara Inc. (NASDAQ: SVRA) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 4.49% on the day to $5.35. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candid...